SCHEMBL20166497

SCHEMBL20166497

COC(=O)c1ccc2c(Br)cn(-c3ccc(F)cc3)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.52
DGAT2 Q96PD7 6/20 0.49
ALDH1A1 P00352 4/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
KDM4E B2RXH2 4/20 0.49
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SCN9A Q15858 2/20 0.43
SCN2B O60939 1/20 0.43
SCN1A P35498 1/20 0.43
SCN1B Q07699 1/20 0.43
SCN5A Q14524 1/20 0.43
NPC1 O15118 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
ALOX12 P18054 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP1A2 P05177 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL142321 0.87 DGAT2 (0.51) HSD17B10DGAT2ALDH1A1KDM4EMEN1
SCHEMBL20166314 0.84 RORC (0.50) DGAT2KDM4ESCN9ASCN2BSCN1A
SCHEMBL4388023 0.80 SCN2B (0.53) HSD17B10DGAT2ALDH1A1KDM4EMEN1
SCHEMBL20166496 0.78 DGAT2 (0.70) DGAT2
SCHEMBL31632933 0.77 HSD17B10 (0.47) HSD17B10ALDH1A1L3MBTL1KDM4ESMN1; SMN2
SCHEMBL19475662 0.77 HSD17B10 (0.47) HSD17B10ALDH1A1L3MBTL1KDM4ESMN1; SMN2
SCHEMBL20166406 0.77 DGAT2 (0.47) DGAT2PARP1
SCHEMBL19510372 0.76 HSD17B10 (0.46) HSD17B10ALDH1A1L3MBTL1KDM4EMEN1
SCHEMBL3972960 0.76 ALDH1A1 (0.59) HSD17B10DGAT2ALDH1A1KDM4EMEN1
SCHEMBL18002655 0.75 KDM4E (0.54) HSD17B10ALDH1A1L3MBTL1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541376-B1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME LLC (US) 2023-04-19 EP disclosed
US-10947222-B2 Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 MERCK SHARP & DOHME CORP. (US) 2021-03-16 US disclosed
EP-3541376-A1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 Merck Sharp & Dohme Corp. (US) 2019-09-25 EP disclosed
US-20190276443-A1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME CORP. (US) 2019-09-12 US disclosed
WO-2018093698-A1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME CORP. (US) 2018-05-24 WO disclosed
WO-2018093698-A1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME CORP. (US) 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947222-B2 Indole derivatives useful as inhibitors of diacylglyceride O-acyltransferase 2 DGAT2, DGAT1, MOGAT2 HSD17B10 104/4885DGAT2 1/4885ALDH1A1 758/4885
US-20190276443-A1 INDOLE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 DGAT2, DGAT1, MOGAT2 HSD17B10 104/4885DGAT2 1/4885ALDH1A1 758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.